Related Experiment Videos
Interleukin-3 production by mast cells from human lung
T Ishizuka1, Y Okayama, H Kobayashi
1First Department of Internal Medicine, Gunma University, School of Medicine, Maebashi, Japan.
Inflammation
|March 5, 1999
Summary
Human lung mast cells release interleukin-3 (IL-3) when stimulated, suggesting a role in airway inflammation and late asthmatic responses. This study investigated IL-3 production by mast cells.
Area of Science:
- Immunology
- Respiratory Medicine
Background:
- Interleukin-3 (IL-3) is a key cytokine in eosinophil and basophil proliferation within the airways.
- Airway inflammation, particularly the late asthmatic response, involves complex cellular and molecular mechanisms.
Purpose of the Study:
- To investigate the production of IL-3 by human lung mast cells.
- To explore the potential role of mast cell-derived IL-3 in the pathogenesis of airway inflammation and late asthmatic responses.
Main Methods:
- Human lung mast cells were purified using affinity magnetic selection with the YB5.B8 monoclonal antibody.
- Mast cells were stimulated with anti-human IgE antibody to mimic allergic reactions.
- Interleukin-3 (IL-3) release was quantified using enzyme-linked immunosorbent assay (ELISA).
- IL-3 messenger RNA (mRNA) expression was analyzed using reverse transcription-polymerase chain reaction (RT-PCR).
- Immunocytochemistry was employed to localize IL-3 within mast cells.
Main Results:
- IL-3 release from mast cells was detected 8 hours after anti-IgE stimulation.
- A significant increase in IL-3 release was observed 24 hours post-stimulation compared to controls.
- IL-3 mRNA was detectable by 2 hours, peaked at 4 hours, and decreased by 8 hours after stimulation.
- Immunocytochemical staining confirmed the presence of IL-3 within mast cells.
Conclusions:
- Human lung mast cells release IL-3 in response to stimulation via the high-affinity IgE receptor.
- Mast cell-derived IL-3 may contribute to airway inflammation, particularly during the late asthmatic response.